• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.25% Nasdaq Up0.65%

    BioMarin Pharmaceutical Inc. (BMRN)

    -NasdaqGS
    89.09 Up 1.83(2.10%) May 27, 4:00PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015
    Total Revenue 236,736   227,936   208,172   250,867  
    Cost of Revenue43,118  42,598  36,719  41,693  
    Gross Profit 193,618   185,338   171,453   209,174  
    Operating Expenses
    Research Development158,793  176,118  158,713  157,901  
    Selling General and Administrative105,300  113,907  94,044  101,514  
    Non Recurring -  198,700   -   -  
    Others10,442  (35,208)616  14,000  
    Total Operating Expenses -  453,517   -   -  
    Operating Income or Loss (80,917) 101,319   (81,920) (64,241)
    Income from Continuing Operations
    Total Other Income/Expenses Net1,769  370,755  1,110  (8,097)
    Earnings Before Interest And Taxes(79,283)102,298  (80,996)(72,541)
    Interest Expense9,843  9,333  9,447  10,002  
    Income Before Tax(89,126)92,965  (90,443)(82,543)
    Income Tax Expense(3,984)24,348  483  (554)
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(85,277)68,339  (91,112)(82,192)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (85,142) 68,617   (90,926) (81,989)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (85,142) 68,617   (90,926) (81,989)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.